Development of an intein-mediated split-Cas9 system for gene therapy.

Truong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O. · 2015

Read Development of an intein-mediated split-Cas9 system for gene therapy. by Truong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4513872.txt.

Description

Dong-Jiunn Jeffery Truong and six co-authors built a split version of the Cas9 gene-editing tool, reported in Nucleic Acids Research in 2015. Cas9 can be aimed at nearly any gene, but its gene is over 4 kilobases long. That size blocks delivery by the small viruses favored for gene therapy.

Each half of Cas9 was fused to half of an intein, a protein piece that splices itself out. When both halves meet in a cell, the inteins join them and rebuild working Cas9. The rejoined tool cut genes as well as normal Cas9 in reporter and cell tests, across three target genes. A nicking variant also worked, and the pair raised the rate of precise repair. Packed into therapy viruses, the split tool still rebuilt and cut.

Catalog record

CREATORTruong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4513872

Browse the full library · About the Tower of Babel